Skip to content

Newsroom

type
year
Illustration image.png

CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel

12/19/2024 Stock exchange release
Illustration image.png

Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel

12/19/2024 Stock exchange release
Illustration image.png

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics

12/18/2024 Press release
orionfi_nuoretkohderyhmana_paakuva1_1500x844.jpg

Pathways to the pharmaceutical industry – This is how Orion encourages young people to find their place

12/13/2024 We are Orion
Illustration image.png

Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction

12/12/2024 Stock exchange release
orion_huoltovarmuus_paakuva_1500x844.jpg

Orion’s Nordic pharmaceutical production means security for all of Europe

12/2/2024 Orion and Society
orion_ajatusjohtaja_parkinsons_paakuva_1500x844.jpg

More than just tremors – What we should understand about Parkinson’s disease

11/27/2024 Your Health
Illustration image.png

142,701 Orion Corporation A shares converted into B shares

11/27/2024 Stock exchange release
Illustration image.png

Orion Research Foundation grants EUR 1,109,000 for research in 2025

11/22/2024 Press release
orionfi_immuno-onkologia_paakuva_1500x844.jpg

Can we treat cancer by activating the body’s own defence system?

11/21/2024 Science and Partnering
Illustration image.png

Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies

11/19/2024 Press release
orionfi_menopaussi_tyopaikalla_paakuva_1500x844.jpg

Shattering the silence: menopause awareness as key to more inclusive work environments

11/12/2024 Orion and Society
orionfi_potilastarina_keuhkoahtauma_paakuva_1500x844.jpg

Päivi Kuoppamäki was diagnosed with COPD at the age of 40: “I avoid situations where I might start laughing”

11/4/2024 Your Health
Illustration image.png

Orion Corporation: Managers’ transactions – Henrik Stenqvist

11/1/2024 Managers transactions
orionfi_jobshadow_paakuva_1500x844.jpg

18-year-old Pyry shadowed the SVP for R&D for a day – “I would love to do socially significant work”

10/30/2024 Orion and Society
Illustration image.png

Orion Group Interim Report January–September 2024

10/29/2024 Stock exchange release
Illustration image.png

Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule

10/24/2024 Stock exchange release
Illustration image.png

Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024

10/15/2024 Press release